tiprankstipranks
Crispr Therapeutics highlights ASGCT oral presentation, announces new programs
PremiumThe FlyCrispr Therapeutics highlights ASGCT oral presentation, announces new programs
3d ago
Crispr Therapeutics management to meet with Mizuho
PremiumThe Fly
Crispr Therapeutics management to meet with Mizuho
17d ago
Crispr Therapeutics management to meet with Mizuho
PremiumThe Fly
Crispr Therapeutics management to meet with Mizuho
17d ago
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
PremiumPress ReleasesCRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
1M ago
Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
PremiumMarket News
Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
1M ago
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
PremiumStock Analysis & Ideas
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
1M ago
Crispr Therapeutics price target raised to $99 from $82 at Mizuho
PremiumThe FlyCrispr Therapeutics price target raised to $99 from $82 at Mizuho
2M ago
Crispr Therapeutics call volume above normal and directionally bullish
PremiumThe Fly
Crispr Therapeutics call volume above normal and directionally bullish
3M ago
Crispr Therapeutics price target raised to $66 from $57 at RBC Capital
PremiumThe Fly
Crispr Therapeutics price target raised to $66 from $57 at RBC Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100